Lv1
6 积分 2026-07-03 加入
Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression
10小时前
已完结
Fibrosis-4 Index as a Robust Long-Term Predictor of Cancers in Metabolic Dysfunction-Associated Steatotic Liver Disease
10小时前
已完结
Hepatocellular carcinoma risk in ICD-coded non-cirrhotic nonalcoholic fatty liver disease refined by fatty liver index: A nationwide South Korean cohort study
10小时前
已完结
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease
10小时前
已完结
Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study
10小时前
已完结
Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease
10小时前
已完结
The effects of HAPA theory-based case management in patients with metabolic dysfunction-associated steatotic liver disease
5天前
已完结
Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease
19天前
已完结
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
21天前
已完结
皖公网安备34019202002308
